Can the United Kingdom control viral hepatitis? - a VHPB Symposium Report

Can the United Kingdom control viral hepatitis? Viral Hepatitis Prevention Board Meeting, Edinburgh, United Kingdom, November 17-18, 2005

Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting report

Hepatitis B is preventable and hepatitis C is treatable even if still at a high cost; most people who are infected with hepatitis B or C virus have not been screened yet and are unaware of their infections; and most countries, especially developing countries, do not have a national plan to prevent and control viral hepatitis. The advent of effective new treatments for hepatitis C has been an ag...

Prevention of viral hepatitis in the Nordic countries and Germany.

The Viral Hepatitis Prevention Board (VHPB) convened a meeting of international experts from the public and private sectors in the Nordic countries and Germany, in order to review the epidemiological situation, the surveillance systems for infectious diseases, the immunization programmes and policy, and the monitoring of adverse events after hepatitis vaccination in those countries, to evaluate...

Viral hepatitis appears on World Health Assembly agenda for first time.

Dr Wiersma was speaking on the sidelines of a meeting in Hong Kong on viral hepatitis in Asia, hosted by the Asia and Pacific Alliance to Eliminate Viral Hepatitis. The meeting brought together clinicians, academics, and government officials from China, Mongolia, and the United Kingdom, as well as agencies such as the US Centers for Disease Control and Prevention and WHO, to discuss what lesson...

Hepatitis B vaccination: how to reach risk groups.

Current hepatitis B vaccination programmes targeting risk groups have met with little success in controlling HBV infection in the general population. Despite the long-standing existence of unambiguous recommendations for risk-group vaccination, hepatitis B vaccination coverage remains low in most risk groups in most high-income countries. This low coverage may be attributed to a lack of perceiv...